DONG-A ST CO.,LTD Logo

DONG-A ST CO.,LTD

Develops, manufactures, and markets drugs, medical devices, and diagnostics.

170900 | KO

Overview

Corporate Details

ISIN(s):
KR7170900005
LEI:
Country:
South Korea
Address:
서울 동대문구 용두동 138 ~255 천호대로 64, 서울

Description

Dong-A ST CO., LTD. is a pharmaceutical company focused on the research, development, manufacturing, and marketing of ethical drugs, medical devices, and diagnostics. The company's portfolio includes proprietary new drugs such as Stillen (gastritis), Zydena (erectile dysfunction), and Motilitone (functional dyspepsia). Operating from cGMP-compliant facilities, it exports a diverse range of products, including novel drugs, generics, and biopharmaceuticals, to global markets. The company maintains a strong commitment to innovative R&D, with a pipeline featuring first-in-class therapeutic candidates for metabolic diseases, including MASH (Metabolic dysfunction-associated steatohepatitis) and obesity, which are being advanced through a dedicated global R&D base.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 5.6 KB
2025-09-09 00:00
투자설명서
Korean 2.8 MB
2025-09-09 00:00
증권발행실적보고서
Korean 47.8 KB
2025-09-08 00:00
[발행조건확정]증권신고서(채무증권)
Korean 14.6 KB
2025-09-03 00:00
[기재정정]증권신고서(채무증권)
Korean 3.1 MB
2025-09-03 00:00
[발행조건확정]증권신고서(채무증권)
Korean 275.8 KB
2025-08-28 00:00
증권신고서(채무증권)
Korean 2.8 MB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 3.3 MB
2025-08-13 00:00
[기재정정]영업(잠정)실적(공정공시)
Korean 18.0 KB
2025-07-25 00:00
주식등의대량보유상황보고서(일반)
Korean 239.2 KB
2025-07-24 00:00
영업(잠정)실적(공정공시)
Korean 13.8 KB
2025-07-24 00:00
기업설명회(IR)개최(안내공시)
Korean 6.6 KB
2025-07-18 00:00
결산실적공시예고(안내공시)
Korean 4.1 KB
2025-07-18 00:00
기업설명회(IR)개최(안내공시)
Korean 6.8 KB
2025-07-07 00:00
최대주주등소유주식변동신고서
Korean 61.5 KB

Automate Your Workflow. Get a real-time feed of all DONG-A ST CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DONG-A ST CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DONG-A ST CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.